Insurance Press Releases
SEE OTHER BRANDS

Your best source on insurance news from the world

Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on May 24, 2025

Rx-Credentialing Achieves Milestone: Over 100 NPs and MDs Engaged with High Retention Rates

Rx-Credentialing Achieves Milestone: Over 100 NPs and MDs Engaged with High Retention Rates

Premium Medical Billing Service is proud to announce that the company now serves over 100 nurse practitioners (NPs) and medical doctors (MDs) across New York. NEW YORK , NY, UNITED STATES, May 24, 2025 /⁨EINPresswire.com⁩/ -- RxCredentialing, a premier …

SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN

SpringWorks Therapeutics erhält positive CHMP-Stellungnahme für Mirdametinib zur Behandlung erwachsener und pädiatrischer Patienten mit NF1-PN

– im Falle einer Marktzulassung wäre Mirdametinib die erste und einzige Behandlung in der Europäischen Union für Erwachsene und Kinder mit NF1-PN – – die Entscheidung der Europäischen Kommission wird für das dritte Quartal 2025 erwartet – STAMFORD, Conn., …

SpringWorks Therapeutics recibe un dictamen positivo del CHMP para el uso de mirdametinib en el tratamiento de la NF1-NP en pacientes adultos y pediátricos

SpringWorks Therapeutics recibe un dictamen positivo del CHMP para el uso de mirdametinib en el tratamiento de la NF1-NP en pacientes adultos y pediátricos

– Si se aprueba, se espera que el mirdametinib sea la primera y única terapia autorizada para el tratamiento de la NF1-NP en la Unión Europea, tanto para adultos como para niños – – Decisión de la Comisión Europea prevista en el tercer trimestre de 2025 – …

SpringWorks Therapeutics reçoit un avis favorable du CMUH pour l’utilisation du mirdamétinib pour le traitement des patients adultes et pédiatriques atteints de NF1-PN

SpringWorks Therapeutics reçoit un avis favorable du CMUH pour l’utilisation du mirdamétinib pour le traitement des patients adultes et pédiatriques atteints de NF1-PN

– S’il est approuvé, le mirdamétinib devrait être le premier et unique traitement dans l’Union européenne à bénéficier d’une autorisation de mise sur le marché pour les adultes et les enfants atteints de NF1-PN – – La décision de la Commission européenne …

SpringWorks Therapeutics: CHMP valuta positivamente Mirdametinib per il trattamento di pazienti adulti e pediatrici affetti da NF1-PN

SpringWorks Therapeutics: CHMP valuta positivamente Mirdametinib per il trattamento di pazienti adulti e pediatrici affetti da NF1-PN

– Se approvato, mirdametinib sarà la prima e unica terapia nell'Unione europea a ottenere l'autorizzazione all'immissione in commercio sia per gli adulti che per i bambini affetti da NF1-PN – – La decisione della Commissione europea è prevista nel terzo …

SpringWorks Therapeutics krijgt positief advies van de CHMP voor Mirdametinib voor de behandeling van volwassen en pediatrische patiënten met NF1-PN

SpringWorks Therapeutics krijgt positief advies van de CHMP voor Mirdametinib voor de behandeling van volwassen en pediatrische patiënten met NF1-PN

- Als mirdametinib wordt goedgekeurd, zal het naar verwachting de eerste en enige therapie in de Europese Unie zijn met een handelsvergunning voor zowel volwassenen als kinderen met NF1-PN - - Besluit van de Europese Commissie wordt verwacht in het derde …

GoHealth, Inc. 投資者消息:若您因 GoHealth, Inc. (NASDAQ: GOCO) 蒙受損失,請聯絡 Rosen Law Firm 了解您的權益

GoHealth, Inc. 投資者消息:若您因 GoHealth, Inc. (NASDAQ: GOCO) 蒙受損失,請聯絡 Rosen Law Firm 了解您的權益

紐約, May 25, 2025 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律師事務所 Rosen Law Firm 宣布代表 GoHealth, Inc. (NASDAQ: GOCO) 的股東,調查 GoHealth 可能向投資公眾發佈重大誤導性業務訊息並就此引發的潛在證券索賠。 影響:若您購買了 GoHealth 證券,您可能有權獲得賠償,並透過勝訴收費安排,免去任何自付費用或開支。 Rosen Law Firm 正準備提出集體訴訟,期望為投資者討回損失。 …

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DNUT

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DNUT

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7 …

Nimanode Launches $NMA Token Presale to Power On-Chain AI Agents on XRP Ledger

Nimanode Launches $NMA Token Presale to Power On-Chain AI Agents on XRP Ledger

Built natively on XRPL, Nimanode enables anyone to deploy AI agents on-chain — now opening early access through its $NMA token presale. LEEDS, United Kingdom, May 24, 2025 (GLOBE NEWSWIRE) -- As XRP futures spark renewed interest in the XRP ecosystem, …

XRP News: XenDex On XRP Offers Its Token $XDX For Sale At Presale Price As Ripple Moves To Acquire Circle While Volatility Shares Launches XRPI Futures ETF

XRP News: XenDex On XRP Offers Its Token $XDX For Sale At Presale Price As Ripple Moves To Acquire Circle While Volatility Shares Launches XRPI Futures ETF

SYDNEY, May 24, 2025 (GLOBE NEWSWIRE) -- In a bold move, Ripple is reportedly in talks to acquire Circle, the issuer of USDC, marking a game-changing moment for the stablecoin space. In addition, Volatility Shares has officially launched the first XRPI …

TechTarget, Inc. 投資者新聞:如果您在 TechTarget, Inc.(NASDAQ: TTGT)蒙受損失,我們鼓勵您聯絡 Rosen Law Firm 以瞭解您的權利

TechTarget, Inc. 投資者新聞:如果您在 TechTarget, Inc.(NASDAQ: TTGT)蒙受損失,我們鼓勵您聯絡 Rosen Law Firm 以瞭解您的權利

紐約, May 25, 2025 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律所 Rosen Law Firm 宣布代表 TechTarget, Inc.(NASDAQ: TTGT)股東調查潛在證券索賠。此事起因為 TechTarget 被控可能向投資大眾發布了嚴重誤導性商務資訊。 影響:如果您購買了 TechTarget 證券,您可能有權獲得賠償,並且根據後酬約定而無需支付任何自付費用或成本。 Rosen Law Firm 在準備一項針對投資者損失進行追討的集體訴訟。 …

Best Crypto to Buy Now: Kaanch Network Sells Out Stage 5

Best Crypto to Buy Now: Kaanch Network Sells Out Stage 5

DUBAI, May 24, 2025 (GLOBE NEWSWIRE) -- Kaanch Network has successfully sold out Stage 5 of its presale, raising $1,303,941 and confirming strong investor demand for early access to its Layer 1 blockchain. With Stage 6 now live at $0.32 per $KNCH, …

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TASK, RDFN, DNB on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TASK, RDFN, DNB on Behalf of Shareholders

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: …

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: …

Break the Limits: 100x Leverage. Double Deposit Bonus. No KYC. Everyone Can Trade Crypto Futures on BexBack

Break the Limits: 100x Leverage. Double Deposit Bonus. No KYC. Everyone Can Trade Crypto Futures on BexBack

SINGAPORE, May 24, 2025 (GLOBE NEWSWIRE) -- With Bitcoin smashing past $100,000, the crypto market is officially back in bull mode. While long-term holders watch their portfolios grow, agile traders know where the real opportunity lies: high-leverage …

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TechTarget, Inc. (NASDAQ: TTGT) resulting from allegations that …

GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth …

Bitcoin Solaris (BTC-S) Presale Ignites Interest as Over $1M Raised Ahead of July 31 Launch

Bitcoin Solaris (BTC-S) Presale Ignites Interest as Over $1M Raised Ahead of July 31 Launch

TALLINN, Estonia, May 24, 2025 (GLOBE NEWSWIRE) -- The next chapter in crypto innovation is unfolding. Bitcoin Solaris (BTC-S), a mobile-first, eco-conscious blockchain project, has officially entered presale mode—raising over $1 million from more than 8, …

Three Keys Lab Fund Defies Market Slump, Doubles AUM and Hits DPI 1 in Q1

Three Keys Lab Fund Defies Market Slump, Doubles AUM and Hits DPI 1 in Q1

Quietly Doubles AUM After Landmark Q1 HONG KONG, May 24, 2025 (GLOBE NEWSWIRE) -- As the Q1 reporting season unfolds, Three Keys Lab Fund recorded results that surprised many crypto sector watchers. The 2022-vintage crypto fund has returned all paid-in …

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

NYC, May 24, 2025 (GLOBE NEWSWIRE) -- NEW YORK, May 24, 2025 / GlobeNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service